Physostigmine pharmacotherapy for anomia

Neurocase

Volumn 2, Issue 2, 1996, Pages 83-91

  Jacobs, Daniel H ^a,b,c   Shuren, Jeffrey ^a   Gold, Michael ^a   Adair, John C ^a   Bowers, Dawn ^a   Williamson, D J G ^a   Heilman, Kenneth M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLCHOLINE; PHYSOSTIGMINE;

ADULT; AGED; ANOMIA; APHASIA; ARTICLE; BRAIN INJURY; CASE REPORT; CHOLINERGIC ACTIVITY; CHOLINERGIC NERVE CELL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOREBRAIN; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; NOMENCLATURE; RANDOMIZED CONTROLLED TRIAL;

EID: 0030014859     PISSN: 13554794     EISSN: None     Source Type: Journal    
DOI: 10.1093/neucas/2.2.83     Document Type: Article

References (34)

1. Aarsland D, Larsen JP, Reinvang I, Aarsland AM. Effects of cholinergic blockade on language in healthy young women: implications for the cholinergic hypothesis in dementia of the Alzheimer type. Brain 1994; 117: 1377-84.
2. Albert ML, Bachman DL, Morgan A, Helms-Estabrooks N. Pharmacotherapy for aphasia. Neurology 1988; 38: 877-9.
3. Amaducci L, Sorbi S, Albanesc A et al. Cholineacetyltransferase (Chat) activity differs in right and left human temporal lobes. Neurology 1981; 31: 799-805.
4. Borkowski JG, Benton AL, Spreen O. Word fluency and brain damage. Neuropsychologia 1967; 5: 135-40.
5. Chatterjee A, Morris MK, Bowers D, Williamson DJ et al. Cholinergic treatment of an amnestic man with a basal forebrain lesion: theoretical implications. Journal of Neurology, Neurosurgery and Psychiatry 1993; 56: 1282-9.
6. Damasio AR, Damasio H. Lesion analysis in neuropsychology. New York: Oxford Press, 1989.
7. Delis D, Kramer J, Kaplan E, Ober B. The California Verbal Learning Test Adult Version. Manual. New York: Psychological Corporation, 1987.
8. Dobkin BH, Hanlon R. Dopamine agonist treatment of anterograde amnesia from a mediobasal forebrain injury. Annals of Neurology 1993; 33: 313-16.
9. Farlow M, Gracon SI, Hershey LA, Lewis KW et al. A controlled trial of tacrine in Alzheimer's disease. Journal of the American Medical Association 1992; 268: 2523-9.
10. Francis WN, Kucera H. Frequency analysis of English usage. Boston: Houghton-Mifflin Company, 1982.
11. Gupta SR, Micoch AG. Bromocriptene treatment of nonfluent aphasia. Archives of Physical Medicine and Rehabilitation 1992; 73: 373-6.
12. Jacobs DH, Shuren J, Bowers D, Heilman KM. Anomia in a patient with a basal forebrain lesion. Neuropsychiatry Neuropsychology and Behavioral Neurology 1995; 8: 200-7.
13. Kaplan EF, Goodglass H, Weinbtraub S. The Boston Naming Test. Boston: Lea and Fabiger, 1983.
14. Kertesz A. Western Aphasia Battery. New York: Grune and Stratton, 1982.
15. Luria AR, Naydin VL, Tsvetkova LS, Vinarskaya EN. Restoration of higher cortical function following local brain damage. In: Vinken PH, Bruyn GW, editors. Handbook of Clinical Neurology. Vol. 3. New York: Elsevier Publishing Company, 1975: 368-433.
16. MacLennan DL, Nicholas LE, Morley GK, Brookshire RH. The effect of bromocriptene on speech and language function in a man with transcortical motor aphasia. Clinical Aphasiology 1991; 21: 145-155.
17. McCormick DA. Cholinergic and noradrenergic modulation of thalamocortical processing. Trends in Neuroscience 1989; 12(6): 215-21.
18. Mesulam M-M, Mufson EJ, Levey AI, Wainer BH. Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience 1983; 11: 1185-1201.
19. Milner B. Visual recognition and recall after right temporal-lobe excision in man. Neuropsychologia 1968; 6: 191209.
20. Nicholas M, Obler LK, Albert ML, Goodglass H. Lexical retrieval in healthy aging. Cortex 1985; 21: 595-606.
21. Osterrieth PA. Le test de copie d'une figure complexe. Archives de Psychologie 1994; 30: 206-356.
22. Peterson LR, Peterson MJ. Short-term retention of individual verbal items. Journal of Experimental Psychology 1959; 58: 193-8.
23. Reitan RM. Validity of the Trail Making Test as an indication of organic brain damage. Perceptual and Motor Skills 1958; 8: 271-6.
24. Sabe L, Leiguarda R, Starkstein SE. An open-label trial of bromocriptene in nonfluent aphasia. Neurology 1992; 42: 1637-8.
25. Sato H, Hata Y, Masui H, Tsumoto T. A Functional role of cholinergic innervation to neurons in the cat visual cortex. Journal of Neurophysiology 1987; 58(4): 765-80.
26. Schaltenbrand G, Bailey P. Introduction to stereotaxis with an atlas of the human brain. Stuttgart: Georg Thieme, 1959.
27. Shuren J, Geldmacher D, Heilman KM. Nonoptic aphasia: aphasia with preserved confrontation naming in Alzheimer's disease. Neurology 1993; 43: 1900-7.
28. Small SL. Pharmacotherapy of aphasia: a critical review. Stroke 1994; 25: 1282-9.
29. Sorbi S, Bracco L, Piacentini S et al. Chemical lateralization in human temporal cortex. Monographs Neural Science 1984; 11: 157-62.
30. Trahan DE, Larrabee GJ. Continuous Visual Memory Test. Odessa, FL: Psychological Assessment Resources, 1988.
31. Walker-Batson D, Devous M, Curtis S, Unwin D et al. Response to amphetamine to facilitate recovery from aphasia subsequent to stroke. Clinical Aphasiology 1991; 21: 137-43.
32. Wechsler D. A standardized memory scale for clinical use. Journal of Psychology 1945; 19: 87-95.
33. Wechsler D. Wechsler Memory Scale - Revised. San Antonio: Harcourt Brace Jovanovich, 1987.
34. Zung WK. A self-rating depression scale. Archives of General Psychiatry 1965; 12: 63-70.